October 31, 2014

Miami-Dade Business Profile

Biscayne Pharmaceuticals

| 8/14/2013
Samuel Reich and Andrew Schally (sitting)
Samuel Reich (standing) and Andrew Schally

For more than half a century, Nobel Prize-winning scientist and University of Miami faculty member Andrew Schally has been researching the hormones that stimulate growth in the body’s tissues. Now his work is being used by Miami-based Biscayne Pharmaceuticals, which was founded last year and licensed from UM the rights to Schally’s inventions related to that research. The company, which Schally works with as scientific adviser, is using his discovery to develop possible treatments for cancer and heart disease.

Biscayne Pharma got going after a $1.5-million investment from its co-founders and Miami Beach investment firm Reich Group, whose Managing Partner Samuel Reich joined Biscayne Pharma as CEO. “This is a breakthrough that will really transform the way we treat cancer,” Reich says.

Tags: Miami-Dade, Healthcare, Technology/Innovation

Digital Access

DIRECT DIGITAL ACCESS
Add digital to your current subscription, purchase a single ditgital issue, or start a new subscription to Florida Trend.

TABLE OF CONTENTS
An overview of the features and articles in this month's issue of Florida Trend.

ACCESS THIS ISSUE »

Florida Business News

Florida Trend Video Pick

Roberto Muñoz - Banking in Florida
Roberto Muñoz - Banking in Florida

Roberto Muñoz, president of the Florida International Bankers Association (FIBA), talks about FIBA, services the organization provides to the state's banks and issues facing banks today.

Earlier Videos | Viewpoints@FloridaTrend

Ballot Box

Walmart and Amazon are kicking off the holiday shopping season Nov. 1. Your thoughts?

  • It's too soon!
  • This news doesn't surprise me
  • Good for them - l like shopping early

See Results

Ballot Box
Subscribe